Search Within

Shanu Modi

  1. "Melanoma Disease Management Team"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
Groups
  1. Breast Medicine Service (6)
  2. Department of Medicine (6)
  3. Melanoma Disease Management Team (6)
  4. Solid Tumor Oncology Division (6)
  5. Hematologic Malignancies, Division of (3)
  6. Population Sciences Research Program (3)

More Groups

People
  1. Christopher Klebanoff (2)
  2. Dana Rathkopf (2)
  3. Daniel Danila (2)
  4. Elizabeth Comen (2)
  5. Karen Autio (2)
  6. Mario Lacouture (2)

More People

Years
  1. 2024 (1)
  2. 2022 (2)
  3. 2021 (1)
  4. 2019 (1)
  5. 2014 (1)
Publications
  1. Breast Cancer Research and Treatment (2)
  2. Clinical Cancer Research (1)
  3. Cornea (1)
  4. Journal of Clinical Oncology (1)
  5. npj Breast Cancer (1)
Publishers
  1. Springer (2)
  2. American Association for Cancer Research (1)
  3. American Society of Clinical Oncology (1)
  4. Lippincott Williams & Wilkins (1)
  5. Nature Publishing Group (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients
    Journal Article

    Gu, S.; Dusza, S.; Quigley, E.; Haliasos, H.; Markova, A.; Marchetti, M.; Moy, A. P.; Dang, C.; Modi, S.; Lake, D.; more...
    Breast Cancer Research and Treatment (2024)

    Fulltext@MSK | Save
  • Refractive shifts and changes in corneal curvature associated with antibody-drug conjugates
    Journal Article

    Canestraro, J.; Hultcrantz, M.; Modi, S.; Hamlin, P. A.; Shoushtari, A. N.; Konner, J. A.; Tew, W. P.; Iyengar, N. M.; Heinemann, M.; Abramson, D. H.; more...
    Cornea (2022)

    Fulltext@MSK | Save
  • Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases
    Journal Article

    Page, D. B.; Beal, K.; Linch, S. N.; Spinelli, K. J.; Rodine, M.; Halpenny, D.; Modi, S.; Patil, S.; Young, R. J.; Kaley, T.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Immunomodulatory activity of a colony-stimulating factor-1 receptor inhibitor in patients with advanced refractory breast or prostate cancer: A phase I study
    Journal Article

    Autio, K. A.; Klebanoff, C. A.; Schaer, D.; Kauh, J. S. W.; Slovin, S. F.; Adamow, M.; Blinder, V. S.; Brahmachary, M.; Carlsen, M.; Comen, E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase 1 study of LY3022855, a colony-stimulating factor-1 receptor (CSF-1R) inhibitor, in patients with metastatic breast cancer (MBC) or metastatic castration-resistant prostate cancer (MCRPC)
    Meeting Abstract

    Autio, K. A.; Klebanoff, C. A.; Schaer, D.; Kauh, J. S.; Slovin, S. F.; Blinder, V. S.; Comen, E. A.; Danila, D. C.; Hoffman, D. M. J.; Kang, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: A case series
    Journal Article

    Sibaud, V.; Niec, R. E.; Schindler, K.; Busam, K. J.; Roché, H.; Modi, S.; Delord, J. P.; Lacouture, M. E.
    Breast Cancer Research and Treatment (2014)

    Fulltext@MSK | Save